Our results suggest that Aβ accumulation may enhance the SUMOylation of TOM40 by downregulating SENP6, which leads to impaired mitochondrial protein import and triggers mitochondria dysfunction, thereby potentially enhancing the pathological process of AD. Here, TOMM40 is linked to Alzheimer disease.